Bayesian enhancement two‐stage design for single‐arm phase II clinical trials with binary and time‐to‐event endpoints
From MaRDI portal
Publication:4628377
DOI10.1111/BIOM.12864zbMath1414.62475OpenAlexW2793110446WikidataQ50024539 ScholiaQ50024539MaRDI QIDQ4628377
Publication date: 13 March 2019
Published in: Biometrics (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1111/biom.12864
posterior probabilityhighest posterior density intervalphase II clinical trialSimon's designsurvival endpointBayesian adaptive design
Applications of statistics to biology and medical sciences; meta analysis (62P10) Reliability and life testing (62N05) Response surface designs (62K20)
This page was built for publication: Bayesian enhancement two‐stage design for single‐arm phase II clinical trials with binary and time‐to‐event endpoints